The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index; 209 of the 276 sources its claims cite were checked for support.
Abstract
Neurodegenerative diseases (NDDs), including Alzheimer's Disease (AD), Parkinson's Disease (PD), and Huntington's Disease (HD), share pathologic mechanisms including oxidative stress, mitochondrial dysfunction, and protein aggregation. However, they differ in age of onset and clinical progression. Emerging evidence highlights primary cilia (PC) as a key regulator of neuronal aging and the progression of these diseases. Dysfunctional PC may impair key signaling pathways, such as Sonic Hedgehog (Shh) and Wnt, promote oxidative stress, mitochondrial damage, and epigenetic instability. PC may also influence intercellular communication by regulating the biogenesis of exosomes and modulating tunneling nanotube (TNT) formation, both of which propagate toxic proteins between neurons. Mechanistically, the regulation of ciliary length is disrupted in AD, which leads to ciliary dysfunction that interferes with signaling pathways and promotes the aggregation of amyloid-beta. This amyloid-beta is then propagated through TNTs and exosomes, spreading neuronal damage. In PD, the accumulation of alpha-synuclein (α-syn) also impairs cilia function, thereby compromising the cell's response to oxidative stress. This results in the formation of abnormal TNTs and defective exosome-mediated clearance, ultimately contributing to neurodegeneration. Similarly, the mutant huntingtin protein aggregates within primary cilia in HD, morphologically disrupting them by obstructing intraflagellar transport. Damaged cilia are also associated with increased TNT formation and the exosomal release of toxic proteins, which leads to mitochondrial and epigenetic instability, ultimately promoting neuronal aging. Together, targeting ciliary function and its downstream regulation of TNTs and exosomes may provide a novel approach for slowing or halting disease progression across neurodegenerative diseases.
Overview
CoChat Summary
## TL;DR
This is a literature review on how primary cilia, extracellular vesicles, and tunneling nanotubes may contribute to protein spread, signaling disruption, and disease progression in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. The paper argues that ciliary dysfunction and vesicle-mediated transport form a “dual-hit” framework that may improve biomarker development and inspire new therapeutic strategies.
## Key findings
- The review frames AD, PD, and HD as sharing a triphasic disease process: abnormal protein creation, aggregation or failed clearance, and propagation.
- In AD, ciliary signaling is linked to Aβ and tau pathology; the paper reports that dentate granule cell primary cilia were shortened by ~50% only in models expressing both Aβ and tau, not Aβ alone or tau alone.
- In PD, the paper states that the incidence increased by an average of 61% per year from 1990 to 2019, and links α-syn pathology to ciliary dysfunction, EV release, and TNT-mediated spread.
- In HD, the paper reports a global prevalence of 0.48 per 100,000 person-years (2010–2022) and a U.S. prevalence of 1.76 per 100,000 person-years, and describes CAG repeat thresholds of 36–39 for incomplete penetrance and >40 for clinical disease.
- The paper highlights EV-based biomarker efforts across diseases, including ongoing clinical trials using saliva, blood, CSF, and saliva-derived EVs for AD and PD, and blood-derived EVs for HD.
## Methods
- This is a literature review, not an original empirical study.
- The authors conducted a comprehensive search in PubMed and Google Scholar using terms including “tunneling nanotubes,” “exosomes,” “primary cilia,” and the three target diseases, and included both original research articles and review papers.
- They screened for studies on the intersection of TNTs, exosomes, and primary cilia in neurodegenerative diseases, excluding other NDDs such as frontotemporal dementia, ALS, and Lewy body dementia; additional studies were added from reference lists.
## Limitations
- The paper states that the relationship between clinical manifestations and ciliogenesis remains “correlational rather than causative.”
- It also states that the mechanisms linking Wnt7a, Notch, TNTs, EVs, and ciliary dysfunction remain “largely speculative” and require further validation.
- Evident from the text: the review relies on heterogeneous prior studies from different models and includes many claims based on preclinical and in vitro evidence, so clinical generalizability is limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 3 Ciliary Dysfunction and Protein Propagation in AD, PD, and HD. (A). In AD, Abnormal cleavage of APP generates Aβ, which accumulates at the ciliary basal body, leading to shortened and dysfunctional cilia and impaired signaling. Hyperphosphorylated tau forms tangles, and both Aβ and tau propagate via EVs and TNTs, beginning in the neocortex and entorhinal cortex before spreading more broadly. Disrupted ciliary–autophagy coupling diverts pathogenic cargo toward EV release, amplifying intercellular propagation of toxic proteins. (B). In PD, misfolded α-syn aggregates into Lewy bodies at the basal body, damaging cilia in dopaminergic neurons and impairing Shh signaling. Loss of primary cilia and impaired autophagy enhance EV-mediated α-syn export, while lysosomal damage further drives cargo release. TNT formation, promoted by actin remodeling under ciliary control, provides an additional pathway for α-syn spread from brainstem nuclei upward into cortical circuits. (C). In HD, mutant huntingtin (HTT) accumulates at the centrosome/basal body, producing elongated and dysfunctional cilia and disrupting cilia-dependent signaling. Defects in autophagy and lysosomal trafficking redirect cargo toward secretory pathways, increasing EV release of HTT. Ciliary signaling also directly regulates actin-dependent EV biogenesis. In parallel, actin remodeling promotes TNT formation, including Rhes-driven “tunnels” that transport HTT between neurons, complementing EV-mediated spread observed in patient biofluids. Created in BioRender. Danna, R. (2025) https://BioRender.com/jasqo6c [189].](https://figures.cochat.ai/paper-figures/457a17683c29495b92ad60eae48bb4b0/the-impact-of-neurotoxin-proteins-trafficked-by-primary-cilia-and-extracellular-figure-3.jpg)
![Figure 1 Common and Unique Features of AD, PD, and HD. The Venn diagram illustrates overlapping and distinct aspects of these neurodegenerative disorders, including disease location, clinical presentation, hallmark symptoms, and associated neurotoxic proteins [33].](https://figures.cochat.ai/paper-figures/214648236efc4802babba632178f1a91/the-impact-of-neurotoxin-proteins-trafficked-by-primary-cilia-and-extracellular-figure-1.jpg)

![Figure 4 The Interplay Between EVs, TNTs, and Ciliary Signaling Pathways: Shh, Wnt, and Notch. This figure represents the functional interactions between EVs, TNTs, and ciliary-mediated signaling pathways, demonstrating their dual roles in neuronal maintenance and neurodegenerative disorders. (A). Shh signaling promotes synaptic spine formation and neuronal survival via EV-associated brain-derived neurotrophic factor (BDNF), rescuing dopaminergic neuron loss and motor deficits in PD. Dysregulation of Shh signaling impairs dopaminergic signaling and migration, contributing to inflammation, oxidative stress, and neuronal degeneration. (B). Wnt signaling pathway maintains blood-brain barrier integrity, synaptic resilience, and nigral neuron survival. Abnormal Wnt activity, via the Wnt7a pathway, facilitates tunneling nanotube formation, cytoskeletal remodeling, and EV-mediated propagation of protein aggregates (α-syn, Aβ, mutant huntingtin), linking this pathway to the spread of neurotoxin proteins and neuroinflammation seen in NDDs. (C). Notch signaling mediates EV-driven synaptic remodeling and neuron-neuron communication. Dysregulated Notch signaling may contribute to glial and neuronal reprogramming and neuroinflammation during neurodegeneration. Created in BioRender. Chen, G. (2025) https://BioRender.com/3h40i7a [290].](https://figures.cochat.ai/paper-figures/56974d8eb1414fada55e6164ac75a34d/the-impact-of-neurotoxin-proteins-trafficked-by-primary-cilia-and-extracellular-figure-4.jpg)
Verification
Claims the paper makes
117 Valid · 11 Not valid · 20 Not checked · 13 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In AD, PD, and HD, aging has also been associated with increased telomere attrition [61,62,63].”
§ The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases > 4. Mechanisms and Etiology
What the sources say
- Not checked — no full text of the sourcecites [61] Forero D.A. Gonzalez-Giraldo Y. Lopez-Quintero C. Castro-Vega L.J. Barreto G.E. Perry G. Meta-analysis of Telomere Length in Alzheimer’s Disease J. Gerontol. Ser. A 2016 71 1069 1073 10.1093/gerona/glw053 PMC4945891 27091133 source
- Disputedcites [62] Wu Y. Pei Y. Yang Z. Li K. Lou X. Cui W. Accelerated telomere shortening independent of LRRK2 variants in Chinese patients with Parkinson’s disease Aging 2020 12 20483 20492 10.18632/aging.103878 33122450 PMC7655166 sourceExperimental — accuracy not yet measured
The Results (General characteristics of subjects) report shorter leukocyte telomeres in patients with Parkinson’s disease than in controls, but an association between age and shorter telomeres appeared in controls, not in the Parkinson’s group. The Discussion likewise says age correlated with telomere shortening in controls but not in patients with Parkinson’s disease. The paper does not address Alzheimer’s or Huntington’s disease. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [63] PerezGrovas-Saltijeral A. Ochoa-Morales A. Miranda-Duarte A. Martinez-Ruano L. Jara-Prado A. Camacho-Molina A. Hidalgo-Bravo A. Telomere length analysis on leukocytes derived from patients with Huntington Disease Mech. Ageing Dev. 2020 185 111189 10.1016/j.mad.2019.111189 31759995 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“New emerging evidence shows that mutant HTT sequesters key autophagy regulators, such as p62 and LC3, preventing the clearance of damaged organelles and misfolded proteins [191].”
§ The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases > 4. Mechanisms and Etiology > 4.3. Huntington’s Disease Pathogenesis
What the sources say
- Disputedcites [191] Folger A. Wang Y. The Cytotoxicity and Clearance of Mutant Huntingtin and Other Misfolded Proteins Cells 2021 10 2835 10.3390/cells10112835 34831058 PMC8616338 sourceExperimental — accuracy not yet measured
Section 4.2.5 (page unavailable) reports that LC3 is recruited to mutant HTT inclusion bodies as part of their autophagic clearance, while p62 colocalizes with mutant HTT aggregates. Section 4.2 also says p62 facilitates inclusion-body formation; it does not say mutant HTT sequesters these proteins and thereby prevents clearance of damaged organelles or misfolded proteins. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The functions of exosomes in the brain can be protective or degenerative, depending on the contents and biological signals that they carry [27,28].”
§ The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases > 1. Introduction
What the sources say
- Supportedcites [27] Song Y. Li Z. He T. Qu M. Jiang L. Li W. Shi X. Pan J. Zhang L. Wang Y. M2 microglia-derived exosomes protect the mouse brain from ischemia-reperfusion injury via exosomal miR-124 Theranostics 2019 9 2910 2923 10.7150/thno.30879 31244932 PMC6568171 sourceExperimental — accuracy not yet measured
The Discussion (page not specified) reports that microglial exosomes carrying inflammatory molecules can enhance Parkinson’s disease progression, while M2-derived exosomes protect neurons. It also identifies exosomal miR-124 as a mediator of the protective effect, supporting the claim that effects depend on what exosomes carry. (LLM, conf=0.90)
- Partly supportedcites [28] Genc S. Pennisi M. Yeni Y. Yildirim S. Gattuso G. Altinoz M.A. Taghizadehghalehjoughi A. Bolat I. Tsatsakis A. Hacimuftuoglu A. Potential Neurotoxic Effects of Glioblastoma-Derived Exosomes in Primary Cultures of Cerebellar Neurons via Oxidant Stress and Glutathione Depletion Antioxidants 2022 11 1225 10.3390/antiox11071225 35883716 PMC9311852 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that glioblastoma-derived exosomes increased oxidative damage in cerebellar neurons and suggests that differences in their molecular cargo may explain differences in effect. The Introduction says exosomes carry biological material, but the paper does not establish that exosomes have protective effects in the brain or that their cargo determines a protective-versus-degenerative outcome. (LLM, conf=0.83)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In addition, there are distinct linkages between AD, PD, HD, and the dysfunction of primary cilia (PC), as well as two forms of intercellular transport, including tunneling nanotubes (TNTs), and exosomes [6,7,8,9].”
§ The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases > 1. Introduction
What the sources say
- Partly supportedcites [6] Mohieldin A.M. Alachkar A. Yates J. Nauli S.M. Novel biomarkers of ciliary extracellular vesicles interact with ciliopathy and Alzheimer’s associated proteins Commun. Integr. Biol. 2021 14 264 269 10.1080/19420889.2021.2017099 34992713 PMC8726672 sourceExperimental — accuracy not yet measured
The Introduction links ciliary proteins to Alzheimer’s disease and Parkinson’s disease, and the Results and discussion section reports associations between ciliary extracellular-vesicle proteins and neurodegenerative disorders. The paper does not address Huntington’s disease or tunneling nanotubes, and its protein associations do not establish dysfunction of exosomes across the three diseases. The supplied passages have no page numbers. (LLM, conf=0.88)
- Partly supportedcites [7] Karunakaran K.B. Chaparala S. Lo C.W. Ganapathiraju M.K. Cilia interactome with predicted protein-protein interactions reveals connections to Alzheimer’s disease, aging and other neuropsychiatric processes Sci. Rep. 2020 10 15629 10.1038/s41598-020-72024-4 32973177 PMC7515907 sourceExperimental — accuracy not yet measured
The Discussion links the cilia interactome to Alzheimer’s, Parkinson’s and Huntington’s disease, and describes abnormal cilia in a Huntington’s disease mouse model. The overlap analysis also reports Alzheimer’s- and Parkinson’s-related gene-expression overlaps. These passages do not establish ciliary dysfunction in all three diseases, and no passage found supports the claimed links to tunneling nanotubes or exosomes (searched those terms). Page numbers were unavailable in our copy. (LLM, conf=0.87)
- Partly supportedcites [8] Miyoshi K. Kasahara K. Murakami S. Takeshima M. Kumamoto N. Sato A. Miyazaki I. Matsuzaki S. Sasaoka T. Katayama T. Lack of dopaminergic inputs elongates the primary cilia of striatal neurons PLoS ONE 2014 9 e97918 10.1371/journal.pone.0097918 24830745 PMC4022734 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports elongated striatal neuronal primary cilia in hemiparkinsonian rats, supporting a link between a Parkinson’s disease model and altered primary cilia. The paper does not establish the claimed links involving Alzheimer’s or Huntington’s disease, tunneling nanotubes, or exosomes. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [9] Chakravarthy B. Gaudet C. Menard M. Brown L. Atkinson T. Laferla F.M. Ito S. Armato U. Dal Pra I. Whitfield J. Reduction of the immunostainable length of the hippocampal dentate granule cells’ primary cilia in 3xAD-transgenic mice producing human Aβ1-42 and tau Biochem. Biophys. Res. Commun. 2012 427 218 222 10.1016/j.bbrc.2012.09.056 22995307 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In AD, EVs are enriched in APP fragments, tau, and synaptic proteins; in PD, they carry citrullinated protein signatures, α-syn, SNAP23, and calbindin; and in HD, they contain N-terminal fragments of mutant huntingtin protein with expanded polyglutamine repeats [30,31,32].”
§ The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases > 1. Introduction
What the sources say
- Partly supportedcites [30] Wang S. Kojima K. Mobley J.A. West A.B. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease EBioMedicine 2019 45 351 361 10.1016/j.ebiom.2019.06.021 31229437 PMC6642358 sourceExperimental — accuracy not yet measured
Section 3.5 (page not provided) identifies SNAP23 and calbindin in urinary EVs as candidate Parkinson’s disease biomarkers. Our copy does not substantiate the attributed citrullinated-protein signature or α-synuclein in these EVs; Section 3.2 mentions γ-synuclein, which is a different protein. (LLM, conf=0.87)
- Partly supportedcites [31] Sancandi M. Uysal-Onganer P. Kraev I. Mercer A. Lange S. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease Int. J. Mol. Sci. 2020 21 2743 10.3390/ijms21082743 32326590 PMC7215947 sourceExperimental — accuracy not yet measured
The Discussion (p. unavailable) reports deiminated proteins in EVs from a rat model of pre-motor PD, supporting the citrullinated-protein-signature part. It does not establish that those EVs carry α-synuclein, SNAP23, or calbindin; its α-synuclein discussion concerns other PD models rather than the measured EV cargo. The claim also generalizes a rat-model finding to Parkinson’s disease without that qualification. (LLM, conf=0.87)
- Partly supportedcites [32] Ciregia F. Urbani A. Palmisano G. Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases Front. Mol. Neurosci. 2017 10 276 10.3389/fnmol.2017.00276 28912682 PMC5583211 sourceExperimental — accuracy not yet measured
The Parkinson's Disease section (page not provided) reports α-synuclein in exosomes, including exosomes isolated from patients' CSF. It does not identify citrullinated protein signatures, SNAP23, or calbindin as Parkinson's disease EV cargo; searches for those terms found no supporting passage in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
71 more claims · 57 with their cited sources checked
Create a free account to see all 161 claims and to verify the 2 references still open.
- It may state two separate claims as one. 63
- Probably not a substantial claim. 31
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 2×
“While TNTs represent a more localized and direct transfer of α -syn, exosomes have been shown to spread contents of one cell, such as organelles, plasma membrane components, pathogens, and calcium, to another across far distances [20].”
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Notably, although α -syn appears early in peripheral tissues, brain damage in PD begins in the brainstem and spreads to the cortex [125,133–135].”
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · cited 2×
“3 in the Huntingtin gene [162].”
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653 · cited 2×
“Understanding variant differences helps clinicians understand more accurate prognoses, as some variants are more aggressive than others [239].”
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678 · cited 1×
“Traditionally, AD treatment relied on cholinesterase inhibitors and memantine to manage symptoms [235–237].”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404 · cited 1×
“AD pathogenesis begins with APP being cleaved abnormally by a β or G -secretase, producing A β , which later aggregates to form plaques [92–95].”
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“AD pathogenesis begins with APP being cleaved abnormally by a β or G -secretase, producing A β , which later aggregates to form plaques [92–95].”
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689 · cited 1×
“…signaling pathways like Shh and Wnt, contributing to neuronal resilience and potentially reducing the risk of NDDs. Con-gruently, recent studies have increasingly focused on lifestyle factors as the mainstay of preventive strategy against the development and progression of NDDs [202,203].”
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676 · cited 1×
“Tau, a microtubule-associated protein, subsequently becomes hyperphosphorylated and forms intracellular tangles [73,96].”
Cited by
Xie, H., Zhu, M., Zhu, Z., Tang, J. W., Zhang, R., Ding, Z., Li, J., Wu, Z., Tam, P. K. H., Wang, Q., et al. (2026) · Advanced Science · doi:10.1002/advs.76054 · Cited by 1
“As reported, the accumulation of α -synuclein impairs ciliary function in neurons, thereby compromising the cellular response to oxidative stress [ 54 ].”
New Insights into Neurodegenerative Diseases: Intercellular Transmission
Xiu-lan, J., Zhao, T.-H., Guo, W., Xue, J., & Yin, D. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00991
Metadata
- Authors
- Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M.
- Affiliations
- California Northstate University (US)
- Corresponding author
- Mohieldin, Ashraf M.
- Venue
- Biology
- Publisher
- MDPI AG
- Published
- 2025-12-15
- Volume
- 14
- Issue
- 12
- Pages
- 1787
- ISSN
- 2079-7737 (ISSN-L)
- PMC
- PMC12730237
- OpenAlex
- W4417327889
- Cited by
- 2
- References
- 301
- Citations by year
- 2026: 2
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- College of Graduate Studies, California Northstate University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- primary cilia, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, Huntington's disease, extracellular vesicles, exosomes, tunneling nanotubes, amyloid-beta aggregation, alpha-synuclein, huntingtin aggregation, intraflagellar transport, Sonic hedgehog signaling, Wnt signaling, oxidative stress, mitochondrial dysfunction, epigenetic instability, neuronal aging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases. https://app.cochat.ai/papers/10.3390/biology14121787
- The paper
- Danna, R., Kondle, S., Amar, O., Mabourakh, M., Chen, G., Fadol, W. B., & Mohieldin, A. M. (2025). The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases. Biology. https://doi.org/10.3390/biology14121787
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.